Pelvic inflammatory disease in the People's Republic of China: aetiology and management.
OBJECTIVE
To study the causes of pelvic inflammatory disease (PID) in Shenyang, Northeastern China, and to assess the efficacy of the syndromic management flowchart for PID recommended by World Health Organization (WHO).


METHODS
200 outpatients with PID attending Gynaecologic Clinic of No. 1 and No. 2 hospital of China Medical University in Shenyang, and 155 control women without symptoms underwent pelvic examination, and were tested for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma hominis (MH), bacterial vaginosis (BV), Candida albicans (CA) and Trichomonas vaginalis (TV).


RESULTS
In PID patients, the prevalence of MH was 26%, of BV 26%, of CT 16%, of CA 11%, of TV 4% and of NG 2.5%. In the control population, prevalences were 5.2%, 8.4%, 0%, 5.2%, 0.7%, 0% respectively. MH, BV and CT were significantly more common in PID patients than in controls (P<0.01). One hundred and thirty-seven of the 200 patients with PID (68.5%) returned for follow-up. Symptoms had resolved completely in 64 (47%), and had improved in 68 (50%). There was no improvement in five (4%).


CONCLUSIONS
The management protocol for female lower abdominal pain recommended by WHO is effective in this setting.
The First Clinical College, China Medical University, Shenyang, 110001, China.
Shang
S
Hong
Chen
C
Xin
Ye
Y
Qianhong
Wang
W
Yanan
Xu
X
Wenyan
Rosanna W
RW
Peeling
David
D
Mabey
D000328:Adult; D000818:Animals; D002176:Candida albicans / Q000302:isolation & purification; D016022:Case-Control Studies; D002681:China / Q000453:epidemiology; D002692:Chlamydia trachomatis / Q000302:isolation & purification; D005260:Female; D006801:Humans; D008875:Middle Aged; D019535:Mycoplasma hominis / Q000302:isolation & purification; D009344:Neisseria gonorrhoeae / Q000302:isolation & purification; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology / Q000382:microbiology; D015995:Prevalence; D014246:Trichomonas vaginalis / Q000302:isolation & purification; D016585:Vaginosis, Bacterial / Q000150:complications / Q000382:microbiology